Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation
Company Logo

Destroying Cancer at the Speed of Light®

Clinical Study Underway (68 of 100 Patients Treated)
Expected to complete enrollment at the end of 2024
Expected to complete study at the end of 2026


Bullboard - Investor Discussion Forum Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF | V.TLT.W

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called... see more

TSXV:TLT - Post Discussion

Theralase Technologies Inc. > I often wonder were the ( censored ) is Health Canada !
View:
Post by Oden6570 on Oct 25, 2023 12:28pm

I often wonder were the ( censored ) is Health Canada !

No funding from Canadaian Goverment ! No Grants no research funds nothing at all ! No funding from Cancer Canada whom claims to be looking for a cancer cure and better results from treatments ( BS IMHO ). Perhaps this may explain why TLT has been black listed , we are holding out for higher prices for our Ruvidar and follow up Drugs. Perhaps doing a deal with Gov will tie our future prices lower than what we could get elsewhere. I mean with the recent news release Health Canada can approve study change ( added tratments at docs discresion ) Why not simply approve the drug for use now. Why must we wait for FDA.?

Over 80% of new medicines submitted to the first agency in each year between 2006 and 2014 were, on average, also submitted to Health Canada, but the percentage decreased to 44% for medicines submitted to the first agency in 2020. Similar trends occurred in oncology therapies and orphan status medicines. Canada’s federal government continues with its intention to regulate reduced medicine prices. Adding any tougher price regulations to barriers that must already be overcome to bring medicines to Canadians will further delay or deny patient access. Canada’s policy towards new medicines needs to change from obsessive cost-containment to reviving biopharmaceutical research and manufacturing and ensuring patient access.

Canada falls behind in new drug submissions compared with the United States and Europe - Canadian Health Policy
Comment by Alamir1111 on Oct 25, 2023 1:13pm
Oden you know the priorities of government.. Pride  taxes all kind of phobia  silt and humiliation on world stage. .
Comment by Yajne on Oct 25, 2023 2:06pm
Oden, the incompetent Libs led by JT continue to put the environment as top priority for Canadians. Why? Because it is still the top priority in Quebec, JT's final area of support in Canada, where the Libs continue to pour funds to attract EV battery manufacturers to that province. All other provinces consider affordability as the current top issue/priority. How do we expect any govt support ...more  
Comment by Alamir1111 on Oct 25, 2023 2:16pm
Hi Y spoken like a true canadian.thx bro I'm not alone..ok let's leave politics aside  .Oden asked  I replied
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.


Connect with V.TLT



Investor Presentation

View the Presentation

FACT SHEET

View the Presentation

The Watchlist

The Watchlist
{{currentVideo.videoCaption}}
< Previous Video {{moreVideoText}} Next Video >

Investment Opportunity

The Road to Saving Lives: Clinical Study Underway

  • Clinical Study with 68 of 100 Patients Treated (Enrollment to be completed by end of 2024, with study completed by end of 2026)
     
  • Ground Floor Investment Opportunity in Multi-Billion Dollar Industry
     
  • Best-in-class treatment for NMIBC (according to interim clinical data)
     
  • NMIBC (Non-Muscle-Invasive Bladder Cancer)
     

Facebook

Contact Us

Address:
41 Hollinger Road
Toronto, ON M4B 3G4
Canada

Toll Free:
1-866-THE-LASE (843-5273)
Local Phone:
416-699-LASE (5273)

Email:
info@theralase.com

Fax:
416-699-5250